Evidence map›Paper›PMID 41617815›Full record

ArticleScientific reports2026

The mTOR signaling pathway regulates key steps of mammary gland organoid genesis in a temporal manner.

Aurélie Lacouture, Mame Sokhna Sylla, Lucas Germain, Louis Fréville, Camille Lafront, Cindy Weidmann, Cynthia Jobin, Mathieu Laplante, Marc-Étienne Huot, Jean-Philippe Lambert and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Aurélie LacoutureDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Mame Sokhna SyllaDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Lucas GermainDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Louis FrévilleDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Camille LafrontDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Cindy WeidmannDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Cynthia JobinDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Mathieu LaplanteCentre de recherche sur le cancer de l Université Laval, Québec City, Canada.
Marc-Étienne HuotCentre de recherche sur le cancer de l Université Laval, Québec City, Canada.
Jean-Philippe LambertDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada.
Étienne Audet-WalshDepartment of molecular medicine Faculty of Medicine, Université Laval, Québec City, Canada. etienne.audet-walsh@crchudequebec.ulaval.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of the mammary gland is a complex process that evolves throughout life. It can undergo drastic changes to support lactation, before involuting back to a rudimentary organ after weaning, in a perfectly orchestrated mechanism. This study aimed to identify the pathways coordinating mammary gland organogenesis, using mouse organoids as a model. In developmental assays, the mechanistic target of rapamycin (mTOR) was shown to be a regulator of cellular lineage determination and branching morphogenesis, acting in a time-dependent manner to control these processes. Indeed, mTOR inhibition during the initial growth phase of organoids abrogated the presence of basal epithelial cells, forcing the expansion of the luminal compartment. At later time points during development, mTOR inhibition promoted branching morphogenesis, increasing the organoid capacity to generate branching/buds. Mechanistically, the mTOR signalling inhibition led to alterations in the expression levels of genes and proteins connected to branching morphogenesis, extracellular matrix remodelling, metabolism, and cell migration. Altogether, this study demonstrates the regulatory functions of mTOR in controlling mammary epithelial cells’ capacity to generate organoids.

Indexed as

Mammary Glands, AnimalOrganogenesisOrganoidsSignal TransductionTOR Serine-Threonine KinasesAnimalsCell MovementEpithelial CellsFemaleMiceMorphogenesisSirolimusmTOR protein, mouseSirolimusTOR Serine-Threonine KinasesEstrogensMammary glandMTOROrganoidsRapamycinTorin

Identifiers

PMID41617815
PMCPMC12913954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.